Status:
COMPLETED
Non-invasive Brain Stimulation to Improve Quadriceps Muscle Function After Anterior Cruciate Ligament Reconstruction
Lead Sponsor:
Arcadia University
Conditions:
Anterior Cruciate Ligament Reconstruction
Quadriceps Muscle Weakness
Eligibility:
All Genders
18-35 years
Phase:
PHASE1
Brief Summary
Quadriceps muscle dysfunction persists for years after anterior cruciate ligament reconstruction (ACLR) and is related to poor self-reported outcomes, altered movement patterns and joint loading assoc...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Underwent primary ACL reconstruction within 3-6 months
- Exclusion Criteria include:
- multiple ligament reconstruction
- osteo-chondral procedures
- any previous lower extremity surgery
- previous ACL injury
- Metal or implants in the head or neck
- history of neurological disease, seizures, severe migraines, and concussion within the last 6 months
Exclusion
Key Trial Info
Start Date :
September 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04504344
Start Date
September 15 2020
End Date
July 31 2023
Last Update
August 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ryan Zarzycki
Glenside, Pennsylvania, United States, 19038